FDA Approves Xospata (gilteritinib) for Acute Myeloid Leukemia (AML) with a FLT3 Mutation Print this page November 28, 2018 — The U.S. Food and Drug Administration today approved Xospata (gilteritinib) tablets for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved… Read More »
Nothing is worse than getting to bed early, only to wake up feeling tired. If morning grogginess and exhaustion have been your norm, you probably want to start figuring why you’re still weary after a slumber. Sure, it may not seem like a big deal, but not getting quality sleep can directly impact your life.… Read More »
If you can’t stop picking your skin, you may have a very common condition called skin picking disorder (SPD). We all pick at a scab or a bump from time to time, but for those with SPD, it can be nearly impossible to control those urges. Apart from the cosmetic impact of recurrent skin lesions… Read More »
Tuesday, November 27, 2018 The holidays…decorations, family, friends, cheer, and relaxation as we near the end of the year. Oh, and probably feeling a bit sluggish from high sugar/alcohol intake, stress, lack of exercise and subsequent weight gain. What if we embraced all that’s great about the holidays and just left the rest. Wouldn’t it… Read More »
Mutations in several genes have been found to cause left ventricular noncompaction. Mutations in the MYH7 and MYBPC3 genes have been estimated to cause up to 30 percent of cases; mutations in other genes are each responsible for a small percentage of cases. However, the cause of the condition is often unknown. Most of the… Read More »